Serena Lavorgna

1.7k total citations
30 papers, 771 citations indexed

About

Serena Lavorgna is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Serena Lavorgna has authored 30 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 19 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Serena Lavorgna's work include Acute Myeloid Leukemia Research (24 papers), Retinoids in leukemia and cellular processes (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Serena Lavorgna is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Retinoids in leukemia and cellular processes (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Serena Lavorgna collaborates with scholars based in Italy, United Kingdom and Spain. Serena Lavorgna's co-authors include Francesco Lo‐Coco, Tiziana Ottone, Francesco Buccisano, Adriano Venditti, Mariadomenica Divona, Maria Teresa Voso, Nélida I. Noguera, Sergio Amadori, Luca Maurillo and Emanuele Ammatuna and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Serena Lavorgna

30 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serena Lavorgna Italy 16 504 484 171 144 122 30 771
Juan A. Castillejo Spain 15 552 1.1× 367 0.8× 160 0.9× 153 1.1× 138 1.1× 17 906
Stefan Deneberg Sweden 13 596 1.2× 560 1.2× 103 0.6× 109 0.8× 78 0.6× 26 782
Sridhar Vempati Germany 7 1.1k 2.1× 686 1.4× 67 0.4× 163 1.1× 104 0.9× 9 1.3k
Pauline Schneider Netherlands 18 618 1.2× 512 1.1× 131 0.8× 576 4.0× 143 1.2× 41 1.1k
Emiliano Fabiani Italy 18 419 0.8× 444 0.9× 77 0.5× 96 0.7× 101 0.8× 48 695
Makiko Mochizuki‐Kashio Japan 15 852 1.7× 539 1.1× 109 0.6× 64 0.4× 47 0.4× 27 1.1k
Yebin Ahn United States 3 389 0.8× 251 0.5× 59 0.3× 238 1.7× 102 0.8× 4 601
Julie A.I. Thoms Australia 15 428 0.8× 209 0.4× 111 0.6× 108 0.8× 64 0.5× 26 612
Luca Trentin Italy 15 381 0.8× 178 0.4× 126 0.7× 154 1.1× 81 0.7× 25 556
Monique Passier Netherlands 10 260 0.5× 144 0.3× 75 0.4× 187 1.3× 99 0.8× 11 490

Countries citing papers authored by Serena Lavorgna

Since Specialization
Citations

This map shows the geographic impact of Serena Lavorgna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Lavorgna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Lavorgna more than expected).

Fields of papers citing papers by Serena Lavorgna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Lavorgna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Lavorgna. The network helps show where Serena Lavorgna may publish in the future.

Co-authorship network of co-authors of Serena Lavorgna

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Lavorgna. A scholar is included among the top collaborators of Serena Lavorgna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Lavorgna. Serena Lavorgna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Buccisano, Francesco, Raffaele Palmieri, Alfonso Piciocchi, et al.. (2021). Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. Cancers. 13(5). 1083–1083. 3 indexed citations
3.
Voso, Maria Teresa, Tiziana Ottone, Serena Lavorgna, et al.. (2019). MRD in AML: The Role of New Techniques. Frontiers in Oncology. 9. 655–655. 95 indexed citations
4.
Gurnari, Carmelo, Eleonora De Bellis, Mariadomenica Divona, et al.. (2019). When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia. Chemotherapy. 64(5-6). 238–247. 24 indexed citations
5.
Faraoni, Isabella, Maria Irno Consalvo, Serena Lavorgna, et al.. (2018). The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation. Cancer Letters. 423. 127–138. 24 indexed citations
6.
Ronchini, Chiara, Anna Cleta Croce, Anna De Antoni, et al.. (2017). The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia. Leukemia. 32(4). 911–919. 37 indexed citations
7.
Ronchini, Chiara, Laura Riva, Lucilla Luzi, et al.. (2016). PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias. Leukemia. 31(9). 1975–1986. 6 indexed citations
8.
Angelini, Daniela F., Tiziana Ottone, Gisella Guerrera, et al.. (2015). A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3 -Mutated Clones in Acute Myeloid Leukemia. Clinical Cancer Research. 21(17). 3977–3985. 57 indexed citations
9.
Hasan, Syed K., Tiziana Ottone, Serena Lavorgna, et al.. (2014). Two Novel Methods for Rapid Detection and Quantification of DNMT3A R882 Mutations in Acute Myeloid Leukemia. Journal of Molecular Diagnostics. 17(2). 179–184. 9 indexed citations
10.
Faraoni, Isabella, Mirco Compagnone, Serena Lavorgna, et al.. (2014). BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(3). 462–472. 56 indexed citations
11.
Pelosi, Andrea, Valentina Lulli, Paolo Romania, et al.. (2012). miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene. 32(31). 3648–3654. 53 indexed citations
12.
Ramadan, Safaa, Laura Cicconi, Nélida I. Noguera, et al.. (2012). Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia. Annals of Hematology. 91(12). 1855–1860. 17 indexed citations
13.
Ottone, Tiziana, Laura Cicconi, Syed K. Hasan, et al.. (2011). Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia. Leukemia Research. 36(4). 474–478. 7 indexed citations
14.
Poeta, Giovanni Del, Emanuele Ammatuna, Serena Lavorgna, et al.. (2010). The genotype nucleophosmin mutated and FLT3‐ITD negative is characterized by high bax/bcl‐2 ratio and favourable outcome in acute myeloid leukaemia. British Journal of Haematology. 149(3). 383–387. 10 indexed citations
15.
Mainardi, Sara, Andrea Pelosi, Aymone Gurtner, et al.. (2009). A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. Oncogene. 28(45). 4034–4040. 71 indexed citations
16.
Ottone, Tiziana, Emanuele Ammatuna, Serena Lavorgna, et al.. (2008). An Allele-Specific RT-PCR Assay to Detect Type A Mutation of the Nucleophosmin-1 Gene in Acute Myeloid Leukemia. Journal of Molecular Diagnostics. 10(3). 212–216. 35 indexed citations
17.
Ottone, Tiziana, Syed K. Hasan, Enrico Montefusco, et al.. (2008). Identification of a potential “hotspot” DNA region in the RUNX1 gene targeted by mitoxantrone in therapy‐related acute myeloid leukemia with t(16;21) translocation. Genes Chromosomes and Cancer. 48(3). 213–221. 13 indexed citations
18.
Ammatuna, Emanuele, Serena Lavorgna, Tiziana Ottone, et al.. (2008). Detection of the nucleophosmin gene mutations in acute myelogenous leukemia through RT‐PCR and polyacrylamide gel electrophoresis. European Journal Of Haematology. 82(1). 69–72. 9 indexed citations
19.
20.
Noguera, Nélida I., Emanuele Ammatuna, D Zangrilli, et al.. (2005). Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia. 19(8). 1479–1482. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan A. Castillejo Breakdown of academic impact, for papers by Stefan Deneberg Breakdown of academic impact, for papers by Sridhar Vempati Breakdown of academic impact, for papers by Pauline Schneider Breakdown of academic impact, for papers by Emiliano Fabiani Breakdown of academic impact, for papers by Makiko Mochizuki‐Kashio Breakdown of academic impact, for papers by Yebin Ahn Breakdown of academic impact, for papers by Julie A.I. Thoms Breakdown of academic impact, for papers by Luca Trentin Breakdown of academic impact, for papers by Monique Passier
Rankless by CCL
2026